汉邦科技(688755) - 2025 Q2 - 季度财报

Definitions Definitions of Common Terms The report defines common terms, including company name, controlling shareholder, and subsidiaries, to ensure clear understanding of the content Definitions of Common Terms Example | Common Term | Meaning | | :--- | :--- | | Hanbon Science and Technology, Company, This Company | Jiangsu Hanbon Science and Technology Co., Ltd | | Controlling Shareholder, Actual Controller | Zhang Dabing | | Hanbon Technology | Jiangsu Hanbon Technology Co., Ltd., a wholly-owned subsidiary of Hanbon Science and Technology | Definitions of Professional Terms This section explains key professional terms such as chromatography, separation and purification, small/large molecule drugs, and simulated moving bed, providing a foundation for understanding the company's business and technology Professional Terms Definitions Example | Professional Term | Meaning | | :--- | :--- | | Chromatography | A separation technique and method, specifically liquid chromatography | | Separation and Purification | The process of obtaining a single component substance from a multi-component mixture | | Small Molecule Drugs | Drugs with small molecular weights such as organic compounds, natural products, antibiotics, and peptides | | Large Molecule Drugs | Biological molecules with large molecular weights and complex structures such as proteins, antibodies, and vaccines | Company Profile and Key Financial Indicators Company's Basic Information Hanbon Science and Technology, located in Huaian Economic and Technological Development Zone, provides its legal representative, registered address, website, and email for public reference Company Basic Information | Indicator | Content | | :--- | :--- | | Chinese Name | Jiangsu Hanbon Science and Technology Co., Ltd | | Legal Representative | Zhang Dabing | | Registered Address | No. 10 Xinzhu Road, Huaian Economic and Technological Development Zone; No. 1-9 Jixian Road, Huaian Economic and Technological Development Zone | | Company Website | www.hanbon.com.cn | Contact Persons and Information Contact details for the company's Board Secretary and Securities Affairs Representative are disclosed, including address, phone, and email, to facilitate investor communication Contact Person Information | Position | Name | Phone | | :--- | :--- | :--- | | Board Secretary | Tang Yefeng | 0517-83706908 | | Securities Affairs Representative | Yin Yanfei | 0517-83706908 | Information Disclosure and Document Availability The company designates specific newspapers for information disclosure and publishes reports on the Shanghai Stock Exchange website, with documents available at the Board of Directors' Office - The company's selected information disclosure newspapers include Shanghai Securities News, China Securities Journal, Securities Times, Securities Daily, Economic Information Daily, Financial Times, and China Daily[16][17] - The website address for publishing the semi-annual report is the Shanghai Stock Exchange website (www.sse.com.cn)[17](index=17&type=chunk) Company Stock Overview The company's A-shares are listed on the STAR Market of the Shanghai Stock Exchange under the ticker 'Hanbon Science and Technology' with stock code 688755 Company Stock Overview | Stock Type | Stock Exchange and Board | Stock Abbreviation | Stock Code | | :--- | :--- | :--- | :--- | | RMB Ordinary Shares (A-shares) | STAR Market of Shanghai Stock Exchange | Hanbon Science and Technology | 688755 | Key Accounting Data and Financial Indicators During the reporting period, the company's operating revenue increased by 5.99%, but total profit, net profit attributable to shareholders, and non-recurring net profit all declined, while operating cash flow significantly decreased; total assets and net assets attributable to shareholders grew substantially due to IPO proceeds Key Accounting Data (January-June 2025 vs. Prior Year Period) | Indicator | Current Reporting Period (Jan-Jun) (CNY) | Prior Year Period (CNY) | Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 348,743,171.17 | 329,032,974.12 | 5.99 | | Total Profit | 32,201,090.31 | 43,414,789.43 | -25.83 | | Net Profit Attributable to Listed Company Shareholders | 27,797,574.46 | 37,684,884.16 | -26.24 | | Net Profit Attributable to Listed Company Shareholders After Deducting Non-Recurring Gains and Losses | 24,772,111.60 | 37,790,209.76 | -34.45 | | Net Cash Flow from Operating Activities | 8,147,982.16 | 31,167,389.83 | -73.86 | Key Accounting Data (End of Reporting Period vs. End of Prior Year) | Indicator | End of Current Reporting Period (CNY) | End of Prior Year (CNY) | Change (%) | | :--- | :--- | :--- | :--- | | Net Assets Attributable to Listed Company Shareholders | 1,208,627,354.49 | 739,633,059.08 | 63.41 | | Total Assets | 1,801,134,100.70 | 1,324,825,113.36 | 35.95 | Key Financial Indicators (January-June 2025 vs. Prior Year Period) | Indicator | Current Reporting Period (Jan-Jun) | Prior Year Period | Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (yuan/share) | 0.40 | 0.57 | -30.12 | | Diluted Earnings Per Share (yuan/share) | 0.40 | 0.57 | -30.12 | | Basic Earnings Per Share After Deducting Non-Recurring Gains and Losses (yuan/share) | 0.36 | 0.57 | -37.90 | | Weighted Average Return on Net Assets (%) | 3.35 | 5.68 | Decreased by 2.33 percentage points | | R&D Investment as % of Operating Revenue (%) | 6.02 | 6.70 | Decreased by 0.68 percentage points | - Total assets and net assets attributable to listed company shareholders increased by 35.95% and 63.41% respectively, primarily due to the company receiving proceeds from its initial public offering during the reporting period[21] - Net profit attributable to listed company shareholders and net profit after deducting non-recurring gains and losses decreased by 26.24% and 34.45% respectively, mainly due to a decrease in product gross margin during the reporting period[22] - Net cash flow from operating activities decreased by 73.86%, primarily due to increased procurement payments driven by higher orders during the reporting period[22] Non-Recurring Gains and Losses Items and Amounts The company's non-recurring gains and losses totaled CNY 3.025 million during the reporting period, primarily from government grants and non-operating income and expenses Non-Recurring Gains and Losses Items and Amounts | Non-Recurring